Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€6.10
08.10.22
-
08.10.23
-0.82%
15.10.22

buy
Clinuvel Pharmaceuticals

Start price
Target price
Perf. (%)
€12.30
07.10.22
-
07.11.22
2.16%
08.11.22

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€3.63
07.10.22
-
07.10.23
-7.04%
19.11.22

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.88
07.10.22
-
07.10.23
-41.15%
08.11.22

buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€2.32
07.10.22
€5.00
07.10.23
-43.97%
08.10.23

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€338.70
07.10.22
€350.00
07.10.23
7.12%
29.10.22

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.75
06.10.22
€0.000
06.10.23
-61.11%
24.10.22

Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€5.20
06.10.22
-
06.10.23
-7.54%
15.10.22

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€49.40
06.10.22
-
06.10.23
-47.77%
06.10.23

buy
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
06.10.22
€0.10
06.10.23
0.00%
06.10.23

buy
Valbiotis

Start price
Target price
Perf. (%)
€4.97
05.10.22
€5.50
05.10.23
17.51%
06.10.23

Could be worthwhile Investment >10% per year
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€17.24
05.10.22
€18.00
05.10.23
-24.25%
06.10.23

Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.38
03.10.22
€7.00
03.10.23
-44.51%
06.10.22

Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€1.74
03.10.22
€2.35
03.10.23
-15.49%
13.02.23

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Neurosearch As Nam.

Start price
Target price
Perf. (%)
€27.00
03.10.22
-
03.10.23
87.41%
24.04.23

Probably not worthwhile Investment
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€2.14
03.10.22
-
03.10.23
-25.23%
15.10.22

buy
Pieris Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.15
03.10.22
-
03.10.23
-7.38%
15.10.22

Albireo Pharma Inc.

Start price
Target price
Perf. (%)
€18.85
03.10.22
-
03.10.23
17.54%
15.10.22

buy
Albireo Pharma Inc.

Start price
Target price
Perf. (%)
€18.85
02.10.22
-
02.10.23
119.74%
02.04.23

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€1.97
02.10.22
-
02.10.23
21.96%
18.05.23

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.11
02.10.22
-
02.10.23
-8.11%
02.04.23

Zealand Pharma A/s

Start price
Target price
Perf. (%)
€22.80
01.10.22
€11.00
01.10.23
8.33%
15.10.22

Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.50
01.10.22
€5.00
01.10.23
-70.29%
15.10.22

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€272.50
30.09.22
€400.00
31.12.24
4.59%
05.05.23

Could be very worthwhile Investment >20% year